Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition

Neoplasma

Volumn 50, Issue 5, 2003, Pages 357-362

  Reszka, E ^a   Wasowicz, W ^a   Rydzynski, K ^a   Szeszenia Dabrowska, N ^a   Szymczak, W ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Glutathione S transferase; GSTM1; GSTP1; Individual susceptibility; Lung cancer; Metabolic polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG; VALINE; XENOBIOTIC AGENT;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METABOLISM; RISK FACTOR; XENOBIOTIC METABOLISM;

EID: 0242385552     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALEXANDRIE AK, INGELMAN SUNDGERG M, SEIDEGARD J, TORNLING, G, RANNUG A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994; 15: 1785-1790.
2. BOFFETTA P, KOGEVINAS M, SIMONATO L, WILBOURN J, SARACCI R. Current perspectives on occupational cancer risks. Occup Environ Hlth 1995; 4315-4325.
3. BROCKMOLLER J, KERB R, DRAKOULIS N, STAFFELDT B, ROOTS I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994; 54: 4103-4111.
4. CABELGUENNE A, LORIOT MA, STUCKER I, BLONS H, KOUM-BESSON E, BRASNU D, BEAUNE P, LACCOURREYE O, LAURENT-PUIG P, DE WAZIERS I. Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 2001; 93: 725-730.
5. CNUBBEN NHP, RIETJJENS IMCM, WORTELBOER H, VAN ZANDEN J, VAN BLADEREN PJ. The interplay of glutathione-related processes in antioxidant defence. Environ Toxicol Pharmacol 2001; 10: 141-152.
6. FRYER A, ZHAO L, ALLDERSEA J, PEARSON WR, STRANGE RC. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J 1993; 295: 313-315.
7. GSUR A, HAIDINGER G, HOLLAUS P, HERBACEK I, MADERSBACHER S, TRIEB K, PRIDUN N, MOHN-STAUDNER A, VETTER N, VUTUC C, MICKSCHE M. Genetic polymorphism of CYP1A1 and GSTM1 lung cancer risk. Anticancer Res 2001; 21: 2237-2242.
8. GUDMUNDSDOTTIR K, TRYGGVADOTTIR L, EYFJORD JE. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidemiol Biomark Prev 2001; 10: 1169-1173.
9. HECHT SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210.
10. HIDA T, KUWABARA M, ARIYOSHI Y, TAKAHASHI T, SUGIURA T, HOSODA K, NIITSU Y, UEDA R. Serum glutathione S-transferase-π level as a tumor marker for non-small cell lung cancer. Cancer 1994; 73: 1377-1382.
11. HIRVONEN A, BOUCHARDY C, MITRUNEN K, KATAJA V, ESKELINEN M, KOSMA VM, SAARIKOSKI ST, JOURENKOVA N, ANTTILA S, DAYER P, UUSITUPA M, BENHAMOU S. Polymorphic GSTs and cancer predisposition. Chem Biol Interact 2001; 133: 75-80.
12. HIRVONEN A, HUSGAFVEL-PURSIAINEN K, ANTILLA S, VAINO H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993; 1: 1479-1481.
13. Hou SM, FÄT S, NYBERG F. Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environ Mol Mutagen 2001; 38: 83-86.
14. HOULSTON RS. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 1999; 8: 675-682.
15. KIHARA M, KIHARA M, NODA K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 1999; 137: 53-60.
16. LIU YH, TAYLOR J, LINKO P, LUCIER GW, THOMPSON CL. Glutathione S-transferas μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis 1991; 12: 2269-2275.
17. MAYR D, PANNEKAMP U, BARETTON GB, GROPP M, MEIER W, FLENS MJ, SCHEPER R, DIEBOLD J. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. Pathol Res Pract 2000; 196: 469-475.
18. MCWILLIAMS JE, SANDERSON BJS, HARRIS EL, RICHERT-BOE KE, HENNER WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomark Prev 1997; 4: 589-594.
19. MITRUINEN K, JOURENKOVA N, KATAJA V, ESKELINEN M, KOSMA MM, BENHAMOU S, VAINIO H, UUSITUPA M, HIRVONEN A. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomark Prev 2001; 10: 229-236.
20. NAKANISHI Y, KAWASAKI M, BAI F, TAKAYAMA K, PEI XH, TAKANO K, INOUE K, OSAKI S, HARA N, KIYOHARA C. Expression of p53 and glutathione S-transferase-π relates to clinical drug resistance in non-small cell lung cancer. Oncology 1999; 57: 318-323.
21. PARKIN DM, BRAY FI, DEVESA SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4-S66.
22. PERRET CW, CLAYTON RN, PISTORELLO M, BOSCARO M, SCASAINI M, BATES A, BUCKLEY N, JONES P, FRYER AA, GILFORD J, ALLDERSEA J, STRANGE RC. GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, RAS and GSP. Carcinogenesis 1995; 16: 1643-1645.
23. RYBERG D, SKAUG V, HEWER A, PHILLIPS LW, HARRIES LW, WOLF CR, OGREID D, ULVIK A, Vu P, HAUGEN A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997; 12: 1285-1289.
24. SALAGOVIC J, KALINA I, HABALOVA V. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 1999; 48: 465-471.
25. SEIDEGARD J, VORACHEK WR, PERO RW, PEARSON WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-7297.
26. STUCKER I, DE WAZIERS I, CENEE S, BIGNON J, DEPIERRE A, MILLERON B, BEAUNE P, HEMON D. GSTM1, smoking and lung cancer: a case-control study. Int J Epidemiol 1999; 28: 829-835.
27. To-FIGUERAS J, GENE M, GOMEZ-CATALAN J, GALAN MC, FUENTES M, RAMON JM, RODAMILANS M, HUGUET E, CORBELLA J. Glutathione S-transferase Ma (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 1997; 18: 1529-1533.
28. WATSON MA, STEWART R, SMITH G, MASSEY TE, BELL DA. Human glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275-280.
29. WILLEY JC, COY E, BROLLY C, UTELL MJ, FRAMPTON MW, HAMMERSLEY J, THILLY WG, OLSON D, CAIRNS K. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 1996; 114: 262-271.
30. ZATONSKI WA. Malignant Neoplasms in Poland. Warsaw, 1993.